CSB
LUMO

City State Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

City State Bank’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-111
Closed -$1K – 710
2022
Q1 		$1K Hold
111
– – ﹤0.01% 671
2021
Q4 		$1K Buy
+111
New +$933 ﹤0.01% 664

Other funds holding LUMO

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

City State Bank's LUMO Position: Q2 2022 in Review

City State Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2022, closing a stake of 111 shares — an estimated $1K sold.

City State Bank first reported a position in LUMO in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 36 funds tracked by Wall St. Rank hold LUMO as of Q2 2022.

  • City State Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • City State Bank sold 111 Lumos Pharma, Inc. Common Stock shares in Q2 2022, an estimated $1K.
  • City State Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • City State Bank's Lumos Pharma, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2022.

Based on City State Bank's 13F filing for Q2 2022, filed 22 Aug 2022.